(Q37311030)

19 August 2017

Overview of cell-based tools for pre-clinical assessment of immunogenicity of biotherapeutics (English)

1 reference

19 August 2017

Harald Kropshofer

1

1 reference

PubMed ID

18958693

19 August 2017

Thomas Singer

series ordinal

2

1 reference

19 August 2017

1 September 2006

1 reference

Journal of Immunotoxicology

19 August 2017

1 reference

19 August 2017

3

1 reference

19 August 2017

3

1 reference

19 August 2017

131-136

1 reference

Clinical link between MHC class II haplotype and interferon-beta (IFN-beta) immunogenicity.

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Antibody humanization: a case of the 'Emperor's new clothes'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Epoetins: differences and their relevance to immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

Rationally engineered therapeutic proteins with reduced immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910600845625

10.1080/15476910600845625

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18958693